Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The stress hormone copeptin: a new prognostic biomarker in acute illness.

Katan M, Christ-Crain M.

Swiss Med Wkly. 2010 Sep 24;140:w13101. doi: 10.4414/smw.2010.13101. Review.

2.

The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department.

Nickel CH, Bingisser R, Morgenthaler NG.

BMC Med. 2012 Jan 20;10:7. doi: 10.1186/1741-7015-10-7. Review.

3.

Copeptin and its potential role in diagnosis and prognosis of various diseases.

Dobsa L, Edozien KC.

Biochem Med (Zagreb). 2013;23(2):172-90. Review.

5.

C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.

Antonescu-Turcu AL, Tomic R.

Curr Opin Pulm Med. 2009 Mar;15(2):120-5. doi: 10.1097/MCP.0b013e3283218603. Review.

PMID:
19532026
6.

Copeptin: a diagnostic factor for critical patients.

Yilman M, Erenler AK, Baydin A.

Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):3030-6. Review.

7.

Copeptin as a biomarker in heart failure.

Balling L, Gustafsson F.

Biomark Med. 2014;8(6):841-54. doi: 10.2217/bmm.14.50. Review.

PMID:
25224940
8.

Copeptin: a biomarker of cardiovascular and renal function.

Morgenthaler NG.

Congest Heart Fail. 2010 Jul;16 Suppl 1:S37-44. doi: 10.1111/j.1751-7133.2010.00177.x. Review.

9.

[Hormones as biomarkers for diagnosis and prognosis].

Winzeler BF, Christ-Crain M.

Praxis (Bern 1994). 2012 Feb 15;101(4):251-7. doi: 10.1024/1661-8157/a000837. Review. German.

PMID:
22337515
10.

[Role of the neurohypophysis in psychological stress].

Scantamburlo G, Ansseau M, Legros JJ.

Encephale. 2001 May-Jun;27(3):245-59. Review. French.

PMID:
11488255
11.

Copeptin: a new marker in cardiology.

Morawiec B, Kawecki D.

J Cardiovasc Med (Hagerstown). 2013 Jan;14(1):19-25. doi: 10.2459/JCM.0b013e3283590d59. Review.

PMID:
22964653
12.

Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections--hope for hype?

Schuetz P, Christ-Crain M, Müller B.

Swiss Med Wkly. 2009 Jun 13;139(23-24):318-26. doi: smw-12584. Review.

13.

[Copeptin: diagnostic parameter, biomarker, or both?].

Rutishauser J.

Ther Umsch. 2009 Nov;66(11):731-4. doi: 10.1024/0040-5930.66.11.731. Review. German.

PMID:
19885789
14.

Copeptin and cardiovascular disease: a review of a novel neurohormone.

Yalta K, Yalta T, Sivri N, Yetkin E.

Int J Cardiol. 2013 Sep 1;167(5):1750-9. doi: 10.1016/j.ijcard.2012.12.039. Epub 2013 Jan 5. Review.

PMID:
23298558
15.

Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.

Beishuizen A, Thijs LG.

J Endotoxin Res. 2003;9(1):3-24. Review.

PMID:
12691614
17.

Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.

Mastorakos G, Ilias I.

Ann N Y Acad Sci. 2003 Nov;997:136-49. Review.

PMID:
14644820
18.

The hypothalamic-pituitary-adrenal axis in critical illness.

Johnson KL, Rn CR.

AACN Clin Issues. 2006 Jan-Mar;17(1):39-49. Review.

PMID:
16462408
19.

Copeptin as a biomarker in cardiac disease.

Giannopoulos G, Deftereos S, Panagopoulou V, Kossyvakis C, Kaoukis A, Bouras G, Pyrgakis V, Cleman MW.

Curr Top Med Chem. 2013;13(2):231-40. Review.

PMID:
23470080
20.

Regulation of the hypothalamic-pituitary-adrenal axis.

Papadimitriou A, Priftis KN.

Neuroimmunomodulation. 2009;16(5):265-71. doi: 10.1159/000216184. Epub 2009 Jun 29. Review.

PMID:
19571587
Items per page

Supplemental Content

Write to the Help Desk